HOME>Investors>Governance>Board of Directors
-
Composition
2025 BOD Composition
As of Mar. 31, 2025
이사회 구성 현황표 Inside Directors -
- ●
- Jae-Hun Jung(CEO)
-
- Appointed : August 8, 2024
- Term : 3 years
- CEO, Dong-A ST
- M.Pharm(Clinical Pharmacy),
Sungkyunkwan Univ.
-
- ●
- Jae-Hong Park
-
- Appointed : March 31, 2025
- Term : 3 years
- President, Dong-A ST
- Harvard Medical School : Institute of
Proteomics Postdoctoral Fellow
-
- ●
- Dae-Woo Lee
-
- Appointed : August 8, 2024
- Term : 3 years
- Director of Corporate Planning
Department, Dong-A ST - Department of International
Economics, Seoul National University
Outside Directors -
- ●
- Byung-Won Jang(Chairman)
-
- Appointed : March 26, 2024
- Term : 3 years
- Adjunct Professor, Ajou University
College of Pharmacy - Vice President, Korea Pharmaceutical
and Bio-Pharma Manufacturers
Association
-
- ●
- Hak-Jun Kim
-
- Appointed : March 24, 2020
- Term : 3 years
- CEO, PA-Partners administrative affairs
- Master of, Social Pharmacology Sungkyunkwan University
-
- ●
- Dong-Chul Kim
-
- Appointed : March 26, 2024
- Term : 3 years
- B.A. (Business Administration),
Seoul National University - Managing Partner Attorney,
Law firm HYUN(Ltd)
-
- ●
- Bum-Joon Kim
-
- Appointed : March 31, 2025
- Term : 3 years
- Professor, The Catholic University of Korea
- Member, Statutory Interpretation and Deliberation Committee,
Financial Services Commission
-
-
Operation
2025 BOD Operation
As of May. 31, 2025
주식분포 상황 표 No. Date Agenda Recognition Name of Directors Jae-
Hun
Jung
(Attendance rate
: 100%)Jae-
Hong
Park
(Attendance rate
: 83.3%)Dae-
Woo
Lee
(Attendance rate
: 100%)Byung-
Won
Jang
(Attendance rate
: 100%)Bum-
Joon
Kim
(Attendance rate
: 100%)Hak-
Jun
Kim
(Attendance rate
: 100%)Dong-
Chul
Kim
(Attendance rate
: 100%)Agree/Disagree 1 2025.02.06 Approval of Separate Financial Statements and Annual Business Report for the 12th Term Approved Agree Agree Agree Agree Agree Agree Agree Resolution on Prior Approval of a Director’s Self-Dealing Transaction Approved Attended Agree Attended Agree Agree Agree Agree Report on the Results of the 2024 ISO37001 CEO review - Attended Attended Attended Attended Attended Attended Attended 2 2025.02.19 Approval of the Consolidated Financial Statements for the 12th Term Approved Agree Agree Agree Agree Agree Agree Agree Determination of the Record Date for Dividends Approved Agree Agree Agree Agree Agree Agree Agree Declaration of Stock Dividends Approved Agree Agree Agree Agree Agree Agree Agree Report on 2024 Business Performance and 2025 Business Plan - Attended Attended Attended Attended Attended Attended Attended Report on the Operation status of the Internal Accounting Management System by the CEO - Attended Attended Attended Attended Attended Attended Attended 3 2024.02.27 Convocation of the 12th Annual General Meeting of Shareholders Approved Agree Agree Agree Agree Agree Agree Agree 4 2024.03.06 Resolution on the Establishment of a Joint Venture Company in Japan Approved Agree Agree Agree Agree Agree Agree Agree Resolution on Delegation to the CEO for Execution and Extension Approval of Loans in 2025 Approved Agree Agree Agree Agree Agree Agree Agree Execution of New Bank loans Approved Agree Agree Agree Agree Agree Agree Agree Report on the results of the 2024 Board of Directors' Evaluation - Attended Attended Attended Attended Attended Attended Attended Report on the Operation of the 2024 Sub-Committee under the Board of Directors - Attended Attended Attended Attended Attended Attended Attended Evaluation Report on the Operation of the Internal Accounting Management System by the Audit Committee - Attended Attended Attended Attended Attended Attended Attended 5 2024.04.22 Resolution on the Composition of Board Committees Approved Agree Agree Agree Agree Agree Agree Agree Report of 1Q 2025 Business Performances - Attended Attended Attended Attended Attended Attended Attended Report on Safety and Health Management for 2024 and 2025 - Attended Attended Attended Attended Attended Attended Attended Report on R&D Status of Dong-A ST - Attended Attended Attended Attended Attended Attended Attended 6 2024.05.08 Participation in Capital Increase of MetaVia, Inc. Approved Agree Agree Agree Agree Agree Agree Agree 2024 BOD Operation
As of Dec. 31, 2024
주식분포 상황 표 No. Date Agenda Recognition Name of Directors Hee-
Joo
Choi
(Attendance rate
: 100%)Jae-
Sang
Ryu
(Attendance rate
: 100%)Hak-
Jun
Kim
(Attendance rate
: 100%)Bum-
Joon
Kim
(Attendance rate
: 100%)Min-
Young
Kim
(Attendance rate
: 100%)Jae-
Hong
Park
(Attendance rate
: 84.6%)Jae-
Hun
Jung
(Attendance rate
: 76.9%)Byung-
Won
Jang
(Attendance rate
: 100%)Dong-
Chul
Kim
(Attendance rate
: 100%)Dae-
Woo
Lee
(Attendance rate
: 100%)Agree/Disagree 1 2024.02.07 Approval of Separate Financial Statements and Annual Business Report Approved Agree Agree Agree Agree Agree Agree Absence - - - Approval of transaction limits for related parties Approved Agree Agree Agree Agree Agree Agree Absence - - - Approval of Issuance of Unsecured Public Bonds Approved Agree Agree Agree Agree Agree Agree Absence - - - Appointment of Compliance Manager Approved Agree Agree Agree Agree Agree Agree Absence - - - Report of the result of ISO37001 CEO review Attended Attended Attended Attended Attended Attended Attended Absence - - - 2 2024.02.23 Approval of the Consolidated Financial Statements for the 11th Term Approved Agree Agree Agree Agree Agree Agree Absence - - - Convening of the Annual General Meeting of Shareholders Approved Agree Agree Agree Agree Agree Agree Absence - - - 2023 Annual Business Report - Attended Attended Attended Attended Attended Attended Absence - - - Report on the Operation status of the Internal Accounting Management System by the CEO - Attended Attended Attended Attended Attended Attended Absence - - - 3 2024.03.07 The acquisition of Ecowin, Inc. Approved Agree Agree Agree Agree Agree Absence Agree - - - Participation in Aptis.co.,Ltd capital increase Approved Agree Agree Agree Agree Agree Absence Agree - - - Delegation of Authority to the CEO for Execution and Extension/Refinancing of Bank loans Approved Agree Agree Agree Agree Agree Absence Agree - - - FY23 Report on the Operation of Sub-Committee under the Board of Directors - Attended Attended Attended Attended Attended Absence Attended - - - Evaluation Report on the Operation of the Internal Accounting Management System by the Audit Committee - Attended Attended Attended Attended Attended Absence Attended - - - 4 2024.04.24 Appointment of Chairman of the Board of Directors Approved - - Agree Agree Agree Agree Agree Agree Agree - The composition of a committee within the board of directors Approved - - Agree Agree Agree Agree Agree Agree Agree - Provision of Payment Guarantee for Dong-A Charmmed, Inc. Approved - - Agree Agree Agree Agree Agree Agree Agree - Equity investment and joint development of Idience Inc. Approved - - Agree Agree Agree Agree Agree Agree Agree - Approval of Environmental Goals for 2024 Approved - - Agree Agree Agree Agree Agree Agree Agree - Report of 1Q 2024 Business Performances - - - Attended Attended Attended Attended Attended Attended Attended - Report on the results of the 2023 Board of Directors' Evaluation - - - Attended Attended Attended Attended Attended Attended Attended - ESG Materiality Assessment and ESG Implementation Plan Report - - - Attended Attended Attended Attended Attended Attended Attended - Report of 2023-2024 Safety and Health Management - - - Attended Attended Attended Attended Attended Attended Attended - 5 2024.06.14 Follow-up Report on Execution and Extension/Refinancing of loans for Q2 2024 - - - Attended Attended Attended Attended Attended Attended Attended - Execution of New Bank loans Approved - - Agree Agree Agree Agree Agree Agree Agree - Equity Investment in NeuroBo, Inc. Approved - - Agree Agree Agree Agree Agree Agree Agree - 6 2024.06.28 Follow-up Report on Participation in NeuroBo, Inc. Capital Increase - - - Attended Attended Attended Attended Attended Attended Attended - Acquisition of shares of major shareholders of Dong-A Chammed, Inc. Approved - - Agree Agree Agree Agree Agree Agree Agree - Convening of the Extraordinary General Meeting of Shareholders for the 12th Term Approved - - Agree Agree Agree Agree Agree Agree Agree - Establishment of Record Date for the Extraordinary General Meeting of Shareholders Approved - - Agree Agree Agree Agree Agree Agree Agree - 7 2024.07.24 Establishment of ESG Committee and Formulation of Regulations Approved - - Agree Agree Agree Agree Agree Agree Agree - Amendment of Board Regulations Approved - - Attended Attended Attended Attended Attended Attended Attended - Report of 2Q 2024 Business Performances - - - Attended Attended Attended Attended Attended Attended Attended - 8 2024.08.08 Appointment of CEO Approved - - Agree Agree - Absence Agree Agree Agree Agree The composition of a committee within the board of directors Approved - - Agree Agree - Absence Agree Agree Agree Agree Appointment of Compliance Manager Approved - - Agree Agree - Absence Agree Agree Agree Agree Pre-Approval of Director's Concurrent Business Activities Approved - - Agree Agree - Absence Agree Agree Agree Agree 9 2024.09.03 Approval of Asset Contribution for the Establishment of a Foundation Approved - - Agree Agree - Agree Agree Agree Agree Agree 10 2024.09.27 Resolution on Prior Approval of a Director’s Self-Dealing Transaction Approved - - Agree Agree - Agree Attended Agree Agree Agree 11 2024.10.30 Report of 3Q 2024 Business Performances - - - Attended Attended - Attended Attended Attended Attended Attended Follow-up Report on Execution and Extension/Refinancing of loans for 3Q 2024 - - - Attended Attended - Attended Attended Attended Attended Attended 12 2024.12.11 Appointment of Compliance Manager Approved - - Agree Agree - Agree Agree Agree Agree Agree Extension of Maturity for Credit Line Loan Approved - - Agree Agree - Agree Agree Agree Agree Agree Conclusion of Joint Research Agreement Approved - - Agree Agree - Agree Agree Agree Agree Agree Proposal for Amendment of Internal Accounting Control Regulations Approved - - Agree Agree - Agree Agree Agree Agree Agree Follow-up Report on Execution and Extension/Refinancing of loans for 4Q 2024 - - - Attended Attended - Attended Attended Attended Attended Attended 13 2024.12.20 Resolution on Prior Approval of a Director’s Self-Dealing Transaction Approved - - Agree Agree - Agree Attended Agree Agree Agree























